Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.

about

Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.

Item

http://www.wikidata.org/entity/Q49589433

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ultrasound molecular imaging w ...... brosis staging in a rat model.

@en

Ultrasound molecular imaging w ...... brosis staging in a rat model.

@nl

type

Item

label

Ultrasound molecular imaging w ...... brosis staging in a rat model.

@en

Ultrasound molecular imaging w ...... brosis staging in a rat model.

@nl

prefLabel

Ultrasound molecular imaging w ...... brosis staging in a rat model.

@en

Ultrasound molecular imaging w ...... brosis staging in a rat model.

@nl

P1476

Ultrasound molecular imaging w ...... brosis staging in a rat model.

@en

P2093

Jiqing Xuan

http://www.w3.org/2001/XMLSchema#string

Leilei Zhu

http://www.w3.org/2001/XMLSchema#string

Liming Deng

http://www.w3.org/2001/XMLSchema#string

Meng Ao

http://www.w3.org/2001/XMLSchema#string

Yuan Guo

http://www.w3.org/2001/XMLSchema#string

Yuanyi Zheng

http://www.w3.org/2001/XMLSchema#string

Yuli Chen

http://www.w3.org/2001/XMLSchema#string

Zhaoxia Wang

http://www.w3.org/2001/XMLSchema#string

Zhigang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro

Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.

CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Evolving therapies for liver fibrosis.

Development and characterization of a nano-scale contrast agent.

Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell.

Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.

P304

108676-108691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21358

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312560

http://www.w3.org/2001/XMLSchema#string

P932

5752473

http://www.w3.org/2001/XMLSchema#string